Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)
Price and Volume
Detailed Quote| Volume | 1,160,845 |
| Open | 19.93 |
| Bid (Size) | 20.29 (300) |
| Ask (Size) | 20.31 (200) |
| Prev. Close | 20.44 |
| Today's Range | 19.50 - 20.81 |
| 52wk Range | 10.68 - 21.68 |
| Shares Outstanding | 1,000 |
| Dividend Yield | N/A |
Top News
More News
Via MarketBeat
Topics
Earnings
Performance
52-Week Range
6.4% below 52-week high
20.30
10.6852W Low
21.6852W High
1 Week
6.4% below 1-week high
20.301W Low
21.681W High
Amneal Pharmaceuticals, Inc. - Class A Common Stock (AMRX) traded between $10.68 and $21.68 over the past 52 weeks and last traded at $20.30, 6.4% below its 52-week high. Over the past week it ranged between $20.30 and $21.68.
Past 12 Months
-5.3%
-0.2%
+7.7%
+54.8%
+60.3%
+81.3%
1W
-$1.14
1M
-$0.05
3M
+$1.45
6M
+$7.19
YTD
+$7.64
1Y
+$9.11
AMRX was +81.3% over the past year, +54.8% over six months, +60.3% year to date, -5.3% in the last week.
12 Months vs Market
AMRX
+81.3%
DIA
+9.3%
SPY
+10.5%
QQQ
+8.5%
IWM
+14.4%
Over the past 12 months AMRX returned +81.3% versus DIA (Dow) +9.3%, SPY (S&P 500) +10.5%, QQQ (Nasdaq 100) +8.5% and IWM (Russell 2000) +14.4%.
Volume & Liquidity
0.40× 3-mo avg
Today 1,160,845
3-mo avg 2.9M
1W
3.7M
1M
4.2M
3M
2.9M
6M
2.5M
YTD
2.4M
1Y
2.3M
AMRX most recently traded 1,160,845 shares against a 3-month average daily volume of 2.9M.
More News
Read More
Amneal Reports Third Quarter 2026 Financial Results
Today 6:00 EST
Via GlobeNewswire
Amneal (AMRX) Q3 earnings: what to expect
November 02, 2026
Via StockStory
Via StockStory
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
October 13, 2026
Via StockStory
3 Overrated Stocks We Think Twice About
October 09, 2026
Via StockStory
Amneal to Report Third Quarter 2026 Results on November 3, 2026
October 08, 2026
Via GlobeNewswire
3 Low-Volatility Stocks with Open Questions
October 05, 2026
Via StockStory
Why Is Amneal (AMRX) Stock Rocketing Higher Today
September 21, 2026
Via StockStory
Amneal Announces FDA Approval and Launch of Lanreotide Injection
September 18, 2026
Via GlobeNewswire
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
September 18, 2026
Via StockStory
Via StockStory
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
August 19, 2026
Via StockStory
1 Healthcare Stock Worth Your Attention and 2 We Ignore
August 07, 2026
Via StockStory
5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call
August 06, 2026
Via StockStory
Amneal (AMRX) Q2 2026 Earnings Call Transcript ↗
July 30, 2026
Via The Motley Fool
Topics
Earnings
Amneal Pharmaceuticals Q2 Earnings Call Highlights ↗
July 30, 2026
Via MarketBeat
Topics
Earnings
Frequently Asked Questions
Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 20.30
When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 11/03/26 02:12 PM ET
What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 20.30K
How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Amneal Pharmaceuticals, Inc. - Class A Common Stock has 20K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>